Lexaria Bioscience Corp. LEXX
4.06 USD +0.03 (+0.74%)
Nov 4, 2026, 12:18 PM EST
3.88 Day range 4.30
2.43 52-week range 21.60
- YTD
- -56.16%
- 1 year
- -75.62%
Analyst view
Consensus: buy
Buy
Price target (mean) 10.00 +146.3% upside
Now 4.06
- Target (low)
- 8.00
- Target (mean)
- 10.00
- Target (high)
- 12.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy2
- Buy0
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
- 2 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 100.00K | -33.9% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 100.00K | -31.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 548.00K | +18.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 584.50K | +6.7% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 2, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 25, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 10, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Mar 5, 2024 | Maxim Group | Maintained | Buy | Buy |
| Jul 21, 2023 | Maxim Group | Initiated | — | Buy |